title: Is GLUT1 a potential target for in-stent restenosis treatment?
authors.affiliation: 2nd Department of Cardiology and Angiology, Silesian Center for Heart Diseases, Zabrze, Poland; Genomics Laboratory, Kardio-Med Silesia Science and Technology Park, Zabrze, Poland. Electronic address: tadeusz.osadnik@sccs.pl.
authors.forename: Tadeusz
authors.initials: T
authors.lastname: Osadnik
authors.affiliation: Silesian Center for Heart Diseases, Zabrze, Poland.
authors.forename: Kamil
authors.initials: K
authors.lastname: Bujak
authors.affiliation: 3rd Department of Cardiology, School of Medicine with the Division of Dentistry, Medical University of Silesia, Zabrze, Poland.
authors.forename: Andrzej
authors.initials: A
authors.lastname: Lekston
mesh_terms: D023903:Coronary Restenosis / Q000209:etiology* / Q000517:prevention & control*; D051272:Glucose Transporter Type 1 / Q000502:physiology*; D006083:Graft Occlusion, Vascular / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D015607:Stents
chemical_list: D051272:Glucose Transporter Type 1; C495677:SLC2A1 protein, human